Evaluation of the necessity of primary tumor resection for synchronous metastatic colorectal cancer

被引:11
作者
Miyamoto, Yuji [1 ]
Watanabe, Masayuki [1 ]
Sakamoto, Yasuo [1 ]
Shigaki, Hironobu [1 ]
Murata, Asuka [1 ]
Sugihara, Hidetaka [1 ]
Etoh, Kojiro [1 ]
Ishimoto, Takatsugu [1 ]
Iwatsuki, Masaaki [1 ]
Baba, Yoshifumi [1 ]
Iwagami, Shiro [1 ]
Yoshida, Naoya [1 ]
Baba, Hideo [1 ]
机构
[1] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto 8608556, Japan
关键词
Colorectal cancer; Chemotherapy; Surgery; NONOPERATIVE MANAGEMENT; COLON-CANCER; LARGE-BOWEL; CHEMOTHERAPY; FLUOROURACIL; COMBINATION; LEUCOVORIN; OXALIPLATIN; BEVACIZUMAB; MULTICENTER;
D O I
10.1007/s00595-014-0869-5
中图分类号
R61 [外科手术学];
学科分类号
摘要
We evaluated the need for primary tumor resection in patients with colorectal cancer (CRC) and synchronous unresectable metastases who underwent chemotherapy, and identified the associations between the primary tumor characteristics and risk of intestinal obstruction or perforation. We retrospectively analyzed the survival and complication rates of patients with synchronous metastatic CRC treated between April 2005 and December 2011. Of 131 patients, 68 underwent primary tumor resection before chemotherapy, and 63 were treated without resection before chemotherapy. The overall survival (OS) did not significantly differ between the two groups (log-rank P = 0.53). In the resection group, 12 patients (17.6 %) developed postoperative complications. In the non-resection group, 16 patients (25.4 %) required surgical intervention owing to obstruction or perforation during their treatment. Surgical intervention did not affect the OS. A circumferential tumor was a risk factor for obstruction or perforation of the colorectum in non-resected patients (odds ratio = 11.163; P = 0.006). Resection of primary tumors before chemotherapy is unnecessary in selected patients with synchronous metastatic colorectal cancer. A circumferential tumor is a risk factor for obstruction or perforation during chemotherapy in cases without primary tumor resection.
引用
收藏
页码:2287 / 2292
页数:6
相关论文
共 25 条
[1]  
BACON HARRY E., 1964, DIS COLON RECTUM, V7, P211, DOI 10.1007/BF02633635
[2]   Trends in frequency and management of obstructing colorectal cancers in a well-defined population [J].
Cheynel, Nicolas ;
Cortet, Marion ;
Lepage, Come ;
Benoit, Laurent ;
Faivre, Jean ;
Bouvier, Anne-Marie .
DISEASES OF THE COLON & RECTUM, 2007, 50 (10) :1568-1575
[3]   Elective palliative resection of incurable stage IV colorectal cancer: Who really benefits from it? [J].
Costi, Renato ;
Di Mauro, Davide ;
Veronesi, Licia ;
Ardizzoni, Andrea ;
Salcuni, Pierfranco ;
Roncoroni, Luigi ;
Sarli, Leopoldo ;
Violi, Vincenzo .
SURGERY TODAY, 2011, 41 (02) :222-229
[4]   Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer [J].
de Gramont, A ;
Figer, A ;
Seymour, M ;
Homerin, M ;
Hmissi, A ;
Cassidy, J ;
Boni, C ;
Cortes-Funes, H ;
Cervantes, A ;
Freyer, G ;
Papamichael, D ;
Le Bail, N ;
Louvet, C ;
Hendler, D ;
de Braud, F ;
Wilson, C ;
Morvan, F ;
Bonetti, A .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :2938-2947
[5]   Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer [J].
Douillard, JY ;
Hoff, PM ;
Skillings, JR ;
Eisenberg, P ;
Davidson, N ;
Harper, P ;
Vincent, MD ;
Lembersky, BC ;
Thompson, S ;
Maniero, A ;
Benner, SE .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) :3605-3616
[6]   Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial Federation Francophone de Cancerologie Digestive 9601 [J].
Ferrand, F. ;
Malka, D. ;
Bourredjem, A. ;
Allonier, C. ;
Bouche, O. ;
Louafi, S. ;
Boige, V. ;
Mousseau, M. ;
Raoul, J. L. ;
Bedenne, L. ;
Leduc, B. ;
Deguiral, P. ;
Faron, M. ;
Pignon, J. P. ;
Ducreux, M. .
EUROPEAN JOURNAL OF CANCER, 2013, 49 (01) :90-97
[7]   First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases [J].
Galizia, Gennaro ;
Lieto, Eva ;
Orditura, Michele ;
Castellano, Paolo ;
Imperatore, Vincenzo ;
Pinto, Margherita ;
Zamboli, Anna .
ARCHIVES OF SURGERY, 2008, 143 (04) :352-358
[8]   Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200 [J].
Giantonio, Bruce J. ;
Catalano, Paul J. ;
Meropol, Neal J. ;
O'Dwyer, Peter J. ;
Mitchell, Edith P. ;
Alberts, Steven R. ;
Schwartz, Michael A. ;
Benson, Al B., III .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (12) :1539-1544
[9]   Bevacizurnab in combination with fluorouracil and leucovorin: An active regimen for first-line metastatic colorectal cancer [J].
Hurwitz, HI ;
Fehrenbacher, L ;
Hainsworth, JD ;
Heim, W ;
Berlin, J ;
Holmgren, E ;
Hambleton, J ;
Novotny, WF ;
Kabbinavar, F .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) :3502-3508
[10]   Stents for palliation of obstructive metastatic colon cancer - Impact on management and chemotherapy administration [J].
Karoui, Mehdi ;
Charachon, Antoine ;
Delbaldo, Catherine ;
Loriau, Jerome ;
Laurent, Alexis ;
Sobhani, Iradj ;
Van Nhieu, Jeanne Tran ;
Delchier, Jean Charles ;
Fagniez, Pierre-Louis ;
Piedbois, Pascal ;
Cherqui, Daniel .
ARCHIVES OF SURGERY, 2007, 142 (07) :619-623